THERAPY IN WOMEN WITH HYPERTENSION AND ESTROGEN DEFICIENCY IN THE LATE FERTILE PERIOD

Download full text PDF
Issue: 
4
Year: 
2016

M. Khabibulina, Candidate of Medical Sciences, Associate Professor Ural State Medical University, Yekaterinburg Yekaterinburg Consulting and Diagnostic Center

The impact of therapy with an angiotensin-converting enzyme inhibitor (Lisinopril) in combination with a third-generation calcium channel blocker (amlodipine) on blood pressure level, left cardiac remodeling, and silent myocardial ischemia in 133 antihypertensive women with estrogen deficiency in the late fertile period in relation to the genotype of the estrogen receptor gene.
Keywords: 
cardiology
estrogen receptor gene (ESR1 – 397 C>T)
estrogen deficiency
left ventricular hypertrophy
silent myocardial ischemia
late fertile period

It appears your Web browser is not configured to display PDF files. Download adobe Acrobat или click here to download the PDF file.

References: 
  1. Gallagher P., John P. Estrogen regulation of angiotensin-converting enzyme mRNA // Hypertension. – 1999; 33; 323–8
  2. Tereschenko S.N. Polimorfizm genov angiotenzinprevraschajuschego fermenta, angiotenzina II, NO-sintetazy, estrogenovyh retseptorov i gendernye razlichija v ih vlijanii na razvitie serdechno-sosudistoj patologii // Kardiologija. – 2009; 4: 58–62.
  3. Belenkov Ju.N., Mareev V.Ju., Ageev F.T. Ingibitory APF v lechenii serdechno-sosudistyh zabolevanij / M., 2002; 86 s.
  4. Glezer M.G. Rezul'taty Rossijskogo issledovanija effektivnosti i bezopasnosti lizinoprila pri AG pod kontrolem sutochnogo monitorirova-nija AD // Problemy zhenskogo zdorov'ja. – 2007; 1 (2): 1–8.
  5. Karpov Ju.A. Ingibitory APF: ot snizhenija AD do profilaktiki oslozhnenij i uluchshenija prognoza // Serdtse. – 2002; 4: 192–4.
  6. Kisljak O.A. Ingibitor APF lizinopril v lechenii pozhilyh patsientov s sistolo-diastolicheskoj AG // Lechebnoe delo. – 2007; 2: 2–7.
  7. Majchuk E.Ju., Jureneva S.V., Voevodina I.V. i dr. Ispol'zovanie lizinoprila dlja lechenija AG u zhenschin posle ovariektomii pri klimakteriche-skom sindrome. Chelovek i lekarstvo. Tezisy dokladov H Rossijskogo natsio-nal'nogo kongressa. M., 2003; s. 256.
  8. Tatarenko O.K., Nosenko E.M., Alehin M.N. i dr. Vlijanie ingibitora angiotenzinprevraschajuschego fermenta moeksiprila na tsentral'nuju i peri-fericheskuju gemodinamiku u zhenschin s umerennoj AG v period menopauzy // Kardiologija. – 1999; 39 (1): 48–53.
  9. Stimpel M. Antihypertensive treatment in menopausal women – results from a prospective, randomized, double-blind, controlled study comparing an ACE inhibitor with diuretic // Cardiology. – 1998; 89 (4): 271–6.
  10. Zabalgoitia M., Rahman S., Haley W. et al. Comparison of left ventricular mass and geometric remodeling in treatel and untreated men and women above 50 years of age of age with systemic hypertension // Am. J. Cardiol. – 1997; 80: 648–54.
  11. Veber V.R., Rubanova M.P. i dr. Effektivnost' nebivolola, amlodi pina u bol'nyh AG zhenschin v postmenopauze s razlichnymi tipami remodeli-rovanija levogo zheludochka // Kardiovask. ter. i profilakt. – 2004; 3 (6, ch. 2): 15–9
  12. Tereschenko S.N., Demidova I.V. Strukturno-funktsional'noe sostojanie LZh i effektivnost' iAPF perindoprila u bol'nyh s postinfarktnoj SN v zavisimosti ot gena APF // Kardiologija. – 2000; 1: 34–7.
  13. Rybakova M.K., Alehin M.N., Mit'kov V.V. Prakticheskoe rukovodstvo po ul'trazvukovoj diagnostike. Ehokardiografija / M.: ID Vidar-M, 2008; 512 s.
  14. Lang R., Biering M., Devereux R. et al. Recommendations of chambers quantification // Eur. J. Echocardiography. – 2006; 7 (2): 79–108.
  15. Hentonen A. Estrogen receptor 1 genotype is related to coronary intima 15. thickness in young to middle-aged women // Scand. J. Clin. Lab. Invest. – 2007; 67: 380–6.
  16. Figtree G., Lind L. Novel estrogen receptor promoter polymorphism increases ventricular hypertrophic response to hypertension // J. Steroid. Biochem. Mol. Biol. – 2007; 2: 110–8.
  17. Shearman A. Association between estrogen receptor 1 gene variation and cardiovasculardisease // JAMA. – 2003; 17: 2263–70
  18. Herrington D. Role of estrogen receptor α in pharmacogenetics of estrogen action // Curr. Opin. Lipidol. – 2003; 2: 145–50.